The White House is about to announce a new round of drug deals to cut what Americans pay for prescriptions.
The White House is preparing to announce another round of agreements aimed at lowering U.S. prescription drug prices, this time with a group of midsized biotechnology companies. Under the deals, first reported by Bloomberg on August 26, the drugmakers would offer state Medicaid programs the same lower prices they charge for outpatient medicines in other…